These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2652487)

  • 1. Verapamil ameliorates acute cyclosporine A (CsA) nephrotoxicity and improves immunosuppression after cadaver renal transplantation.
    Dawidson I; Rooth P; Fisher D; Fry WR; Alway C; Coorpender L; Reisch J
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1511-3. PubMed ID: 2652487
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention of acute cyclosporine-induced renal blood flow inhibition and improved immunosuppression with verapamil.
    Dawidson I; Rooth P; Fry WR; Sandor Z; Willms C; Coorpender L; Alway C; Reisch J
    Transplantation; 1989 Oct; 48(4):575-80. PubMed ID: 2678635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Verapamil prevents posttransplant delayed function and cyclosporine A nephrotoxicity.
    Dawidson I; Rooth P; Alway C; Dulzo T; Palmer B; Lu C; Peters P; Sagalowsky A; Sandor Z
    Transplant Proc; 1990 Aug; 22(4):1379-80. PubMed ID: 2202113
    [No Abstract]   [Full Text] [Related]  

  • 4. What is cyclosporine nephrotoxicity?
    Myers BD
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1430-2. PubMed ID: 2652460
    [No Abstract]   [Full Text] [Related]  

  • 5. Improvement of cadaver renal transplantation outcomes with verapamil: a review.
    Dawidson I; Rooth P
    Am J Med; 1991 May; 90(5A):37S-41S. PubMed ID: 2039019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elective conversion from cyclosporine to azathioprine and prednisolone in patients after cadaveric renal transplantation: observations on graft survival and renal function.
    Tegzess AM; van Son WJ; de Maar EF; Beelen JM; Sluiter WJ; Huisman RM
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1635-7. PubMed ID: 2652534
    [No Abstract]   [Full Text] [Related]  

  • 7. Chronic cyclosporine nephrotoxicity in renal transplantation: is it the effect of preservation?
    Kumar MS; Samhan M; John P; al-Adnani MS; Abouna GM
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1552-3. PubMed ID: 2652503
    [No Abstract]   [Full Text] [Related]  

  • 8. Cyclosporine-associated nephrotoxicity is not intractable.
    Loertscher R
    Transplant Proc; 1987 Aug; 19(4):3486-9. PubMed ID: 3303520
    [No Abstract]   [Full Text] [Related]  

  • 9. The use of triple therapy to minimize cyclosporine (CsA) nephrotoxicity in renal transplantation.
    Landsberg DN; Rae A; Chiu A; Werb R; Taylor P; Chan-Yan C; Manson AD
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1550-1. PubMed ID: 2652502
    [No Abstract]   [Full Text] [Related]  

  • 10. Cyclosporine in renal transplantation: a single institutional experience.
    Ferguson RM; Sommer BG
    Am J Kidney Dis; 1985 Jun; 5(6):296-306. PubMed ID: 3925761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclosporin nephrotoxicity.
    Neild GH
    Semin Thorac Cardiovasc Surg; 1990 Apr; 2(2):198-203. PubMed ID: 2081228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypertension after renal transplantation. A comparison of cyclosporine and conventional immunosuppression.
    Chapman JR; Marcen R; Arias M; Raine AE; Dunnill MS; Morris PJ
    Transplantation; 1987 Jun; 43(6):860-4. PubMed ID: 3296353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baseline biopsies define cyclosporine nephrotoxicity.
    Belnap LP; Hammond EH; Yowell R; Richards KF; Rees WV; Stevens LE
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1485. PubMed ID: 2652476
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical diagnosis and management of the renal transplant recipient with cyclosporine nephrotoxicity.
    Diethelm AG
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):82-91. PubMed ID: 3515700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclosporine nephrotoxicity: associated allograft dysfunction at low trough concentration.
    Jankauskiene A; Druskis V; Laurinavicius A
    Clin Nephrol; 2001 Dec; 56(6):S27-9. PubMed ID: 11770808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved immunosuppression for secondary cadaver renal transplants (SCT) in high risk patients using quadruple immunosuppression with cyclosporine A (CsA) and rabbit anti-thymocyte globulin (RATG).
    DeMasi R; Thomas F; Cunningham P; Sash C; Clark G; Thomas J
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1729-31. PubMed ID: 2652565
    [No Abstract]   [Full Text] [Related]  

  • 17. Chronic Epstein-Barr virus reactivation after renal transplantation: immunosuppression with cyclosporine versus azathioprine.
    Hillebrand G; Castro LA; Schleibner S; Land W; Gurland HJ
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2179-80. PubMed ID: 2856280
    [No Abstract]   [Full Text] [Related]  

  • 18. Verapamil improves the outcome after cadaver renal transplantation.
    Dawidson I; Rooth P; Lu C; Sagalowsky A; Diller K; Palmer B; Peters P; Risser R; Sandor Z; Seney F
    J Am Soc Nephrol; 1991 Nov; 2(5):983-90. PubMed ID: 1760541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclosporine-induced nephrotoxicity: role of prostaglandins.
    Jorkasky D; Audet P; Williams S; Grossman R; Conrad M
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1742-4. PubMed ID: 3079035
    [No Abstract]   [Full Text] [Related]  

  • 20. Extrarenal pathology of cyclosporine: a lasting challenge.
    Berardinelli L; Raiteri M; Beretta C; Costantino B; Tonello G; Vegeto A
    Transplant Proc; 1990 Oct; 22(5):2343-4. PubMed ID: 2219399
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.